Sector: Pharmaceuticals & Biotechnology

Small Cap

Rekvina Laboratories Share Price

Q: What is the Market Capitalization of Rekvina Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 8 July 2026, the market cap for Rekvina Laboratories Ltd. is approximately ₹ 21.7 Cr.

Q: What are the PE and PB ratios for Rekvina Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Rekvina Laboratories Ltd. is -85.2, and the Price-to-Book (PB) ratio is -17.7.

Q: What is the 52-Week High and Low for Rekvina Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Rekvina Laboratories Ltd. shares was ₹ 46.65, and the lowest price was ₹ 6.75.

Q: Who are the major shareholders of Rekvina Laboratories Ltd.?

Significant shareholdings in Rekvina Laboratories Ltd. typically include entities such as: Public Promoter Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Rekvina Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Rekvina Laboratories Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines and Accretion Nutraveda for analysis and benchmarking.

VINRKLB

₹35

-1.00(-2.78%)

NSE :

Open Free Demat Account

Rekvina Laboratories Performance

Price Movement

N/A

₹35.00

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹35.00

Low₹35.00

Open at₹35.00

Prev Close₹36.00

Volumes1.00 K

Avg Price₹35.00

Lower Circuit₹33.25

Upper Circuit₹36.75

Historical Performance

3M High₹46.65

3M Low₹31.69

1 Yr High₹46.65

1 Yr Low₹6.75

3 Yr High₹46.65

3 Yr Low₹6.75

5 Yr High₹46.65

5 Yr Low₹3.75

Summary

As of 10-07-2026 22:20, Rekvina Laboratories Ltd. share price today is ₹0, with a change of ₹-36.00 (-100.00%) from the previous close of ₹36. The stock opened at ₹35 and traded between ₹35 and ₹35, with a total traded volume of 1000 shares. The company has a market capitalization of ₹21.7 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹46.65 and ₹6.75, respectively.

Rekvina Laboratories Ltd. valuation metrics include a P/E ratio of -85.2, and book value of ₹-17.70. Rekvina Laboratories Ltd. has reported revenue of ₹1.27 Cr and net profit of ₹-0.25 Cr.

Rekvina Laboratories Ltd. technical indicators include Day RSI at 44.42, Day MFI at 62.2, Day ADX at 28.28. Additional indicators include Commodity Channel Index (CCI) at -33.4 and Williams %R at -34.8. Momentum indicators show Day MACD at -1.3, Day MACD Signal Line at -1.18, DayATR at 1.19. Rate of Change indicators for Rekvina Laboratories Ltd. include ROC125 at 852.38 and ROC21 at -18.18.

Exponential moving averages include EMA5 at ₹35.3, EMA10 at ₹35.6, EMA12 at ₹35.8, EMA20 at ₹36.7, EMA26 at ₹37.1, EMA50 at ₹37.1, EMA100 at ₹32.8, EMA200 at ₹25. Simple moving averages include SMA5 at ₹34.8, SMA10 at ₹35.1, SMA20 at ₹37.2, SMA30 at ₹38.2, SMA50 at ₹39.4, SMA100 at ₹34.7, SMA150 at ₹25.1, SMA200 at ₹20.1.

Support levels for Rekvina Laboratories are placed at First Support ₹36.00, Second Support ₹36.00, Third Support ₹36.00. Resistance levels are seen at First Resistance ₹36.00, Second Resistance ₹36.00, Third Resistance ₹36.00. Rekvina Laboratories Ltd. shareholding pattern shows promoter holding at 41.3%, FII holding at 0%, DII holding at 0%, public holding at 58.72%.

Rekvina Laboratories Fundamentals

Market Cap

Low in industry

21.70 Cr.

PE Ratio (TTM)

Negative PE TTM

-85.20

Dividend Yield

Net Profit TTM

79% decr over last year

-0.25

Net Profit Growth

79% decr over last year

-0.25

PEG Ratio

Above industry Median

ROE

Operating Revenue TTM

1.27

Operating Revenue Growth

Book Value

Negative Price to Book

-17.70

MFI

MFI is mid-range

62.20

RSI

RSI is mid-range

44.42

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

-17.70

Rekvina Laboratories Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025
Total Revenue	0.72	0.35	0.20	0	0
Operating Expense	0.78	0.47	0.23	0.04	0.04
Operating Profit	-0.06	-0.12	-0.03	-0.04	-0.04
Depreciation	0	0	0	0	0
Interest	0	0	0	0	0
Tax	0	0	0	0	0
Net Profit	-0.06	-0.12	-0.03	-0.04	-0.04

Rekvina Laboratories Technicals

Rekvina Laboratories Ltd. EMA & SMA

₹35.00

-1.00 (-2.78%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹35.3

Day EMA10 ₹35.6

Day EMA12 ₹35.8

Day EMA20 ₹36.7

Day EMA26 ₹37.1

Day EMA50 ₹37.1

Day EMA100 ₹32.8

Day EMA200 ₹25

Rekvina Laboratories Support and Resistance

Resistance

First Resistance₹36.00

Second Resistance₹36.00

Third Resistance₹36.00

Support

First Support₹36.00

Second Support₹36.00

Third Support₹36.00

Technical Indicators

Day RSI44.42

Day MFI62.20

Day ADX28.28

Day Commodity Channel Index-33.40

William-34.80

Day MACD-1.30

Day MACD Signal Line-1.18

Day ATR1.19

Day ROC125852.38

Day ROC21-18.18

Rekvina Laboratories Shareholding Pattern

Held By	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Promoter	41.3	41.3	41.3	41.3	41.3	41.3
FII	0	0	0	0	0	0
DII	0	0	0	0	0	0
Public	58.7	58.7	58.7	58.7	58.7	58.7

Rekvina Laboratories Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	198	198	100.00%
Week	2.01 K	2.01 K	100.00%
1 Month	1.14 K	1.14 K	100.00%
6 Month	4.52 K	4.52 K	100.00%

Rekvina Laboratories SWOT Analysis

Strengths9

Weakness9

Opportunity0

Threats0

Consistent high performing stocks over Five Years

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Relative Outperformance versus Industry over 1 Week

Growth in Net Profit with increasing Profit Margin (QoQ)

Increasing Revenue every quarter for the past 3 quarters

Companies with Zero Promoter Pledge

Highest Recovery from 52 Week Low

Stock with Low PE (PE < = 10)

Rekvina Laboratories Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Rekvina Laboratories Stock Comparison

Financials	Goldline Pharmaceutical Ltd.	Sai Parenterals Ltd.	Speciality Medicines Ltd.	Accretion Nutraveda Ltd.	Vivimed Labs Ltd.
Price (₹)	₹41	₹587.60	₹183.50	₹259.30	₹5.40
% Change	0.00%	-1.43%	-0.27%	0.00%	-0.18%
Revenue TTM (₹ Cr)	-	-	-	-	₹83.60
Net Profit TTM (₹ Cr)	-	-	-	-	₹-34.95
PE TTM	9.60	-	12.40	37.00	-1.30
1 Year Return		52.07			441
ROCE	-	3.56	-	-	-5.63

Similar Stocks

APPL

Aptus Pharma Ltd.

₹ 224.00

+1.93%

AMANTA

Amanta Healthcare Ltd.

₹ 179.17

-2.00%

AHCL

Anlon Healthcare Ltd.

₹ 15.60

+0.84%

PATELCHEM

Patel Chem Specialities Ltd.

₹ 95.00

-1.04%

APL

Asston Pharmaceuticals Ltd.

₹ 76.50

+1.32%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 535.00

-0.10%

ASTONEALAB

Astonea Labs Ltd.

₹ 282.55

+1.99%

AMWILL

Amwill Health Care Ltd.

₹ 41.00

-3.91%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 62.00

-0.26%

SHELTER

Shelter Pharma Ltd.

₹ 27.40

+6.41%

TLL

Trident Lifeline Ltd.

₹ 262.50

-0.61%

DPL

Dipna Pharmachem Ltd.

₹ 5.76

-8.86%

ACHYUT

Achyut Healthcare Ltd.

₹ 8.20

+0.12%

SIGACHI

Sigachi Industries Ltd.

₹ 22.67

+1.98%

WINDLAS

Windlas Biotech Ltd.

₹ 830.00

+0.50%

VINEETLAB

Vineet Laboratories Ltd.

₹ 32.80

+0.43%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 38.55

-4.98%

CHCL

Cian Healthcare Ltd.

₹ 8.67

+0.00%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 568.90

+0.36%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.41

+0.00%

ZIMLAB

Zim Laboratories Ltd.

₹ 113.62

-1.99%

BPLPHARMA

Bharat Parenterals Ltd.

₹ 1402.00

-0.61%

MEDICO

Medico Remedies Ltd.

₹ 39.10

+0.03%

SGRL

Shree Ganesh Remedies Ltd.

₹ 687.00

+1.43%

FAQ's on VINRKLB

What is the Market Capitalization of Rekvina Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 8 July 2026, the market cap for Rekvina Laboratories Ltd. is approximately ₹ 21.7 Cr.

What are the PE and PB ratios for Rekvina Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Rekvina Laboratories Ltd. is -85.2, and the Price-to-Book (PB) ratio is -17.7.

What is the 52-Week High and Low for Rekvina Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Rekvina Laboratories Ltd. shares was ₹ 46.65, and the lowest price was ₹ 6.75.

Who are the major shareholders of Rekvina Laboratories Ltd.?

Significant shareholdings in Rekvina Laboratories Ltd. typically include entities such as:

Public
Promoter
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Rekvina Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Rekvina Laboratories Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines and Accretion Nutraveda for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy